生物智造中心

Search documents
安琪酵母: 安琪酵母股份有限公司关于实施生物智造中心建设项目的公告
Zheng Quan Zhi Xing· 2025-06-26 16:06
Core Viewpoint - The company plans to implement a Biomanufacturing Center construction project with an estimated total investment of 502.25 million yuan to enhance its biotechnology research and industrialization process [1][2]. Project Overview - The project was approved by the company's board of directors with unanimous support during the third meeting of the Strategic and Sustainable Development Committee [1]. - The project requires further approval from the shareholders' meeting after the board's approval [2]. - The project is not classified as a related party transaction or a major asset restructuring [2]. Basic Project Details - The construction area is 27,687.65 square meters, including two underground levels and 297 parking spaces [2]. - The project will involve the acquisition of equipment for strain selection, cell factory construction, intelligent fermentation, separation and purification, and analysis and testing [2]. - The project will utilize existing water and electricity supplies from the company headquarters and will implement an integrated wastewater treatment system [2]. Environmental Protection - The project will adhere to sustainable development principles and comply with national environmental protection regulations [2]. - Wastewater, domestic waste, and construction waste will be handled according to standards, and new systems will be installed following relevant building and fire safety laws [2]. Necessity Analysis - The project aims to integrate resources to accelerate the research and application of new technologies and processes, transitioning the company's biomanufacturing from traditional to intelligent, green, and high-end models [3]. - It aligns with the company's strategic goal of becoming a leading global yeast enterprise and a first-class international biotechnology company [3]. Impact on the Company - The project aligns with the company's 14th Five-Year Plan and is expected to significantly enhance its technological innovation capabilities in biomanufacturing [4]. - It will further strengthen the company's sustainable profitability and overall competitiveness, contributing to stable development without harming the interests of the company and its shareholders [4].